Le Lézard
Classified in: Ebola virus, Health, Business
Subject: ERN

ZINZINO AB (PUBL): INTERIM REPORT THIRD QUARTER 2023


GOTHENBURG, Sweden, Nov. 16, 2023 /PRNewswire/ -- 

GOING TOWARDS RECORD RESULTS IN 2023 AFTER ANOTHER VERY STRONG QUARTER

The total revenues during the third quarter of 2023 amounted to SEK 436.9 (349.9) million, which corresponded to 25% (12%) growth compared to the corresponding quarter of the previous year. The EBITDA result increased to SEK 71.2 (25.4) million for the quarter and the EBITDA margin increased to 16.3% (7.3%). As before, behind the margin improvement are primarily changes in the sales mix, efficiencies and economies of scale. During the quarter, a very successful sales launch was carried out in Mexico and BalanceTest no. 1,000,000 were analyzed at Vita's laboratory in Oslo, Norway. Given the good development, the board maintains its full-year forecast, which indicates that 2023 will be a record year.

JULY-SEPTEMBER

JANUARY-SEPTEMBER

Link to the report:
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/

For more information please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, email: [email protected]
Fredrik Nielsen CFO Zinzino +46 707 900 174, email: [email protected]

Images for free publication :
[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag.

This information is information that Zinzino AB (publ) is obliged to make public according to the EU's market abuse regulation. The information was provided by the above contact person for publication at 08.00 on 16 November 2023.

The following files are available for download:

https://mb.cision.com/Main/10976/3876765/2433862.pdf

Zinzino interim Report Q3 2023

https://mb.cision.com/Public/10976/3876765/a3c011b9fa7fb49a.pdf

Press Release Zinzino Interim Report Q3 2023

 


These press releases may also interest you

at 10:02
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDMtm Platform. Located in Belo Horizonte, Brazil, the Instituto Mário Penna...

at 10:01
Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces the results of a groundbreaking independent study led by Mayo Clinic and presented at Digestive Disease Week...

at 10:00
Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA). A new trial led by the Center for Regenerative Medicine...

at 10:00
Latham & Watkins LLP1 is pleased to announce that Jennifer Bragg and William (Bill) McConagha have joined the firm's Healthcare & Life Sciences Practice in the Washington, D.C. office. Bragg and McConagha bring a powerful combination of deep...

at 10:00
SightMD, a leading multi-specialty ophthalmology practice in...

at 10:00
A trailblazing new concept combining a mind, body, and soul approach to personal growth and fitness is coming to an area near you! Todd Durkin, internationally recognized mindset coach, and fitness trainer behind some of the...



News published on and distributed by: